Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, July 13, 2014 11:14:58 AM
bullish weekly trade 20-30% on margin (=107-186%/mo)
added to the Russell 2000 index so it may be bought by index funds
$GALT
DD Notes ~ http://www.ddnotesmaker.com/GALT
##### recent news/filings ~ source: finance.yahoo.com
Wed, 09 Jul 2014 12:54:02 GMT ~ Galectin Therapeutics Added to Russell 2000 Index
[at noodls] - NORCROSS, Ga., July 9, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that ...
read full: http://www.noodls.com/view/B070711C03C232DCD4BC9DD68D53B5D1CDF25043
*********************************************************
Wed, 09 Jul 2014 12:30:00 GMT ~ Galectin Therapeutics Added to Russell 2000 Index
[GlobeNewswire] - NORCROSS, Ga. -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that it has been added to the Russell 3000(R) Index ...
read full: http://finance.yahoo.com/news/galectin-therapeutics-added-russell-2000-123000224.html
*********************************************************
Thu, 03 Jul 2014 16:42:06 GMT ~ Could Galectin Therapeutics Stock Be Your Next Home Run?
read full: http://www.fool.com/investing/general/2014/07/03/could-galectin-therapeutics-stock-be-your-next-hom.aspx?source=eogyholnk0000001
*********************************************************
Thu, 26 Jun 2014 13:40:00 GMT ~ Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs
[Accesswire] - WHITEFISH, MT / June 26, 2014 / Those following the developments of Intercept Pharmaceuticals (NASDAQ: ICPT), Galectin Therapeutics (NASDAQ: GALT) and Galmed Pharmaceuticals (NASDAQ: GLMD) are keenly aware ...
read full: http://finance.yahoo.com/news/catalysts-horizon-companies-developing-nafld-134000256.html
*********************************************************
Mon, 23 Jun 2014 17:44:55 GMT ~ BUZZ-U.S. Stocks on the Move-American Apparel, Willdan, Agile Therapeutics
read full: http://uk.finance.yahoo.com/news/buzz-u-stocks-move-american-174455407.html
*********************************************************
##### chart ~ source: stockcharts.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GALT/company-info
Ticker: $GALT
OTC Market Place: Not Available
CIK code: 0001133416
Company name: Galectin Therapeutics Inc.
Company website: http://www.galectintherapeutics.com
Incorporated In: NV, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001133416&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/GALT/filings
Latest financials: http://www.otcmarkets.com/stock/GALT/financials
Latest news: http://www.otcmarkets.com/stock/GALT/news - http://finance.yahoo.com/q/h?s=GALT+Headlines
Major holdings: http://data.cnbc.com/quotes/GALT/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=GALT+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/GALT.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=GALT
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=GALT&search=search
DTCC: http://search2.dtcc.com/?q=Galectin+Therapeutics+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Galectin+Therapeutics+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Galectin+Therapeutics+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.galectintherapeutics.com
Alexa: http://www.alexa.com/siteinfo/http://www.galectintherapeutics.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.galectintherapeutics.com
Short Sales: http://www.otcmarkets.com/stock/GALT/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/GALT/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/GALT/research
Historical Prices: http://finance.yahoo.com/q/hp?s=GALT+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=GALT+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=GALT+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=GALT+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=GALT+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=GALT+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=GALT
Balance Sheet: http://finance.yahoo.com/q/bs?s=GALT
Cash Flow: http://finance.yahoo.com/q/cf?s=GALT+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/GALT
Bloomberg: http://www.bloomberg.com/quote/GALT:US
Morningstar: http://quotes.morningstar.com/stock/s?t=GALT
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=GALT
Barchart: http://www.barchart.com/quotes/stocks/GALT
OTC Short Report: http://otcshortreport.com/index.php?index=GALT
Investopedia: http://www.investopedia.com/markets/stocks/GALT/?wa=0
http://www.pennystocktweets.com/stocks/profile/GALT
##### last known share structure ~ source: otcmarkets.com
Market Value: $284,369,280 a/o Jul 11, 2014
Shares Outstanding: 21,908,265 a/o May 09, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Galectin is a clinical development-stage biopharmaceutical company based in Norcross, Georgia, that is targeting fibrotic diseases and cancer with novel galectin inhibitor compounds. Galectins are a class of proteins made by many cells in the body and are important therapeutic targets because they are the mediators of fundamental biologic mechanisms in pathological processes. Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new compounds. Through a relationship with a world-class research program at the University of Georgia, the Company focuses on the discovery of new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role including cancer and inflammatory and fibrotic disorders.Less >>
DD Notes ~ http://www.ddnotesmaker.com/GALT
a11k
Recent GALT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 05:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:55:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:51:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:50:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:48:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:47:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:44:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:43:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:40:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 04:23:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 01:07:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 01:41:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 04:42:44 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:50:50 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 01:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 10:19:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2023 02:21:40 PM
- UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:45:52 PM
- Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:55:24 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM